Health

Cybin Partners with Osmind to Accelerate Commercial Preparation for its Clinical-Stage Psychiatry Programs - Cybin will leverage Osmind's 800-clinic network,...

Valeo Pharma financial results have showcased a promising trajectory with a reported 3% increase in revenues for the three months...

- 100% of participants were responsive to treatment and 71% of participants were in remission at 12 months after just...

Minimal residual disease (MRD) assessment has emerged as a game-changing biomarker in the multiple myeloma (MM) treatment landscape. Over the...

Boston Pharmaceuticals' next-generation, long-acting FGF21 analog, efimosfermin alfa (BOS-580), has demonstrated positive results in a Phase 2 trial for metabolic...

Single dose of RN0191 achieved up to 95% individual maximum and 87% mean maximum PCSK9 reduction, and up to 74%...

Growth of UK facility will enable clinical-grade manufacturing of drug substances for range of biopharmaceutical products BURLINGTON, Mass., Nov. 14, 2024 /CNW/...

Gilead Sciences is implementing a strategic restructuring, including workforce reductions at its Kite Pharma subsidiary and the closure of its...

Fresh off the successful $1.25 billion acquisition of Yellow Jersey Therapeutics by Johnson & Johnson, Kaken Pharmaceutical and Numab Therapeutics...

Drug delivery specialist Halozyme Therapeutics has launched a $2.1 billion (€2 billion) takeover bid for Evotec, a leading drug discovery...